RUA Life Sciences plc Share Price

Equities

AOR

GB0033360586

Advanced Medical Equipment & Technology

Market Closed - London S.E. 09:05:23 26/04/2024 pm IST 5-day change 1st Jan Change
10.75 GBX +4.88% Intraday chart for RUA Life Sciences plc -2.27% +9.14%

Financials

Sales 2024 * 2.24M 2.8M 234M Sales 2025 * 3.28M 4.1M 342M Capitalization 6.67M 8.33M 695M
Net income 2024 * -1M -1.25M -104M Net income 2025 * - 0 0 EV / Sales 2024 * 1.34 x
Net cash position 2024 * 3.66M 4.57M 381M Net cash position 2025 * 2.95M 3.68M 307M EV / Sales 2025 * 1.14 x
P/E ratio 2024 *
-2.48 x
P/E ratio 2025 *
-7.17 x
Employees 48
Yield 2024 *
-
Yield 2025 *
-
Free-Float 79.93%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.88%
1 week-2.27%
Current month+19.44%
1 month+17.49%
3 months-12.60%
6 months-12.24%
Current year+9.14%
More quotes
1 week
10.00
Extreme 10
10.88
1 month
8.50
Extreme 8.5
14.30
Current year
8.50
Extreme 8.5
14.30
1 year
8.50
Extreme 8.5
58.75
3 years
8.50
Extreme 8.5
168.00
5 years
8.50
Extreme 8.5
180.00
10 years
8.00
Extreme 8
180.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 01/21/01
Chairman 55 21/11/21
Director/Board Member 71 31/16/31
Members of the board TitleAgeSince
Chairman 55 21/11/21
Director/Board Member 73 -
Director/Board Member 57 18/21/18
More insiders
Date Price Change Volume
26/24/26 10.75 +4.88% 535,404
25/24/25 10.25 0.00% 246,695
24/24/24 10.25 -4.65% 577,459
23/24/23 10.75 0.00% 53,279
22/24/22 10.75 -2.27% 276,581

Delayed Quote London S.E., April 26, 2024 at 09:05 pm IST

More quotes
RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.
More about the company

Annual profits - Rate of surprise